Technical Analysis for BBLG - Bone Biologics Corp
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 1.53 | -4.68% | -0.07 |
Earnings due: May 6
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing Low | Bearish | 0.00% | |
| New 52 Week Low | Weakness | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| NR7 | Range Contraction | -4.68% | |
| Narrow Range Bar | Range Contraction | -4.68% | |
| Wide Bands | Range Expansion | -4.68% | |
| Oversold Stochastic | Weakness | -4.68% | |
| New 52 Week Closing Low | Bearish | -4.68% | |
| Stochastic Reached Oversold | Weakness | -4.68% |
| Alert | Time |
|---|---|
| Down 5% | about 21 hours ago |
| 60 Minute Opening Range Breakdown | about 21 hours ago |
| Down 3% | about 21 hours ago |
| Fell Below Previous Day's Low | about 21 hours ago |
| Down 2 % | about 21 hours ago |
Get a Trading Sidekick!
- Earnings date: 05/06/2024
Bone Biologics Corp Description
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. Its NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. The company is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. Its platform technology has application in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Biopharmaceutical Clinical Medicine Surgery Neurosurgery Platform Technology Orthopedic Surgery Sports Medicine Surgical Specialties Spinal Fusion Degenerative Disc Disease Spinal Fusion Applications
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 72.0 |
| 52 Week Low | 1.46 |
| Average Volume | 90,338 |
| 200-Day Moving Average | 4.77 |
| 50-Day Moving Average | 2.34 |
| 20-Day Moving Average | 1.78 |
| 10-Day Moving Average | 1.66 |
| Average True Range | 0.21 |
| RSI (14) | 31.51 |
| ADX | 20.62 |
| +DI | 11.75 |
| -DI | 21.08 |
| Chandelier Exit (Long, 3 ATRs) | 1.64 |
| Chandelier Exit (Short, 3 ATRs) | 2.10 |
| Upper Bollinger Bands | 2.13 |
| Lower Bollinger Band | 1.42 |
| Percent B (%b) | 0.15 |
| BandWidth | 40.08 |
| MACD Line | -0.21 |
| MACD Signal Line | -0.23 |
| MACD Histogram | 0.0183 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.75 | ||||
| Resistance 3 (R3) | 1.75 | 1.68 | 1.71 | ||
| Resistance 2 (R2) | 1.68 | 1.62 | 1.68 | 1.70 | |
| Resistance 1 (R1) | 1.60 | 1.59 | 1.57 | 1.60 | 1.69 |
| Pivot Point | 1.53 | 1.53 | 1.51 | 1.53 | 1.53 |
| Support 1 (S1) | 1.45 | 1.47 | 1.42 | 1.45 | 1.36 |
| Support 2 (S2) | 1.38 | 1.44 | 1.38 | 1.35 | |
| Support 3 (S3) | 1.31 | 1.38 | 1.34 | ||
| Support 4 (S4) | 1.30 |
